遗传分析鉴定的VAV2基因在开角型青光眼中的疾病机制研究

批准号:
81970839
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
黄璐琳
依托单位:
学科分类:
青光眼、视神经及视路疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
黄璐琳
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
青光眼是全球第二大致盲原因,开角型青光眼(POAG)是其主要类型之一。POAG以视网膜神经节细胞(RGC)凋亡为特征,与遗传因素紧密相关,但目前鉴定的POAG基因仅可解释约 5%的POAG发病。我们通过398例POAG和1374例对照样本的高深度全外显子组测序,挖掘到VAV2基因的稀有变异在POAG样本中显著富集;同时,我们通过大样本亚洲人群的POAG meta分析,发现VAV2基因内含子的SNP位点rs7852459与POAG显著相关;而文献报道Vav2-/-小鼠眼压升高,提示VAV2可能是POAG的疾病基因。为此,本课题在前期研究的基础上,开展VAV2基因与POAG的疾病机制研究,从突变/变异对功能的影响、RGC功能及信号通路维持、小鼠模型的表型等多方面开展研究,发现VAV2基因异常导致POAG的分子机制,为理解VAV2基因在调控RGC稳态中的关键作用和POAG的干预治疗提供依据。
英文摘要
Glaucoma is the secondary leading cause of blindness worldwide. Open-angle glaucoma (POAG) is one of its main types. POAG is characterized by apoptosis of retinal ganglion cells (RGC) and is closely related to genetic factors. However, only about 5% of the pathogenesis of POAG can be explained by the identified POAG genes. We performed 398 POAG and 1374 control samples‘’ whole exome sequencing, and found that the rare variants in VAV2 genes were significantly enriched in POAG samples. Meanwhile, we found that the SNP locus rs7852459 in the intron of VAV2 gene was significantly associated with POAG in the results of meta-analysis of POAG in Asians. The literature reported that intraocular pressure of Vav2-/- mice was increased. All these clues suggested that VAV2 might be a disease gene of POAG. Therefore, on the basis of previous studies, this proposal mean to explore the molecular mechanisms between VAV2 and POAG. We will study the effects of mutation/variation on the function of VAV2, the role of VAV2 in maintenance of RGC function, its signaling pathway, as well as the detailed phenotypes of Vav2-/- and hVAV2 knockin mice models. The results obtained from this study would provide proofs not only for understanding the key role of VAV2 gene in regulating RGC homeostasis but also for intervention therapy of POAG in the future.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.gendis.2022.11.007
发表时间:2023-11
期刊:GENES & DISEASES
影响因子:6.8
作者:Huang, Lulin;Ye, Lin;Li, Runze;Zhang, Shanshan;Qu, Chao;Li, Shujin;Li, Jie;Yang, Mu;Wu, Biao;Chen, Ran;Huang, Guo;Gong, Bo;Li, Zheng;Yang, Hongjie;Yu, Man;Shi, Yi;Wang, Changguan;Chen, Wei;Yang, Zhenglin
通讯作者:Yang, Zhenglin
Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy.
年龄相关性黄斑变性:流行病学、遗传学、病理生理学、诊断和靶向治疗
DOI:10.1016/j.gendis.2021.02.009
发表时间:2022-01
期刊:Genes & diseases
影响因子:6.8
作者:Deng Y;Qiao L;Du M;Qu C;Wan L;Li J;Huang L
通讯作者:Huang L
DOI:--
发表时间:2020
期刊:实用医院临床杂志
影响因子:--
作者:王 晶;黄璐琳;林 婴;杨正林
通讯作者:杨正林
A comprehensive map of disease networks and molecular drug discoveries for glaucoma.
青光眼疾病网络和分子药物发现的综合图谱。
DOI:10.1038/s41598-020-66350-w
发表时间:2020
期刊:Scientific Reports
影响因子:4.6
作者:Wang Haixin;Deng Yanhui;Wan Ling;Huang Lulin
通讯作者:Huang Lulin
DOI:10.1016/j.gendis.2021.05.004
发表时间:2022-03
期刊:Genes & diseases
影响因子:6.8
作者:Huang L;Fang L;Liu Q;Torshizi AD;Wang K
通讯作者:Wang K
RP新基因剪接因子PRPF4B突变鉴定及分子机制研究
- 批准号:82271105
- 项目类别:面上项目
- 资助金额:52万元
- 批准年份:2022
- 负责人:黄璐琳
- 依托单位:
FGD6基因息肉状脉络膜血管病变致病机制研究
- 批准号:81670895
- 项目类别:面上项目
- 资助金额:62.0万元
- 批准年份:2016
- 负责人:黄璐琳
- 依托单位:
家族性渗出性玻璃体视网膜病变Wnt信号通路新的关键基因识别及功能研究
- 批准号:81300802
- 项目类别:青年科学基金项目
- 资助金额:25.0万元
- 批准年份:2013
- 负责人:黄璐琳
- 依托单位:
国内基金
海外基金
